arznei-telegramm Logo a-t Kurzlogo
    ❮ a-t 9/2025 a-t ❯
    This is a translation of the table of contents. One article of each issue is translated and freely available.
    table of contents
    SPOT ON

    Switching from other NOACs to rivaroxaban generics?

    NEW ON THE MARKET

    Rimegepant (VYDURA) for preventive treatment of migraine

    THERAPY FROM A CRITICAL VIEWPOINT

    High-dose influenza vaccine EFLUELDA: new data

    Once again: beta-blockers after myocardial infarction without reduced ejection fraction?

    Anticoagulation after ablation of atrial fibrillation

    IN BRIEF

    Hyaluronic acid against knee or hip osteoarthritis?

    Carpal tunnel syndrome: surgery or injection?

    Protection of minors fails: e-cigarettes are gateway drugs

    a-t READERS QUESTIONS AND COMMENTS

    On the risk of anaphylaxis with parenteral iron

    SIDE EFFECTS

    Agranucytosis with clozapine: new instructions for blood count monitoring

    Liver damage due to cannabidiol (CBD)

    Yet again: ashwagandha and liver damage
    free

    e a-t ON THE INTERNET

    Once again: beta-blockers after myocardial infarction without reduced ejection fraction? (long version)

    arznei-telegramm

    Independent drug information – in English

    Concise, critical evaluations of drugs and medical devices for evidence-based therapy and patient advice on benefits and risks – independent, ad-free and funded exclusively by subscriptions.

    Browse free articles

    Wir schätzen Ihr Feedback

    Nehmen Sie an unserer Umfrage teil!